NCT07114354Not yet recruiting
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 11 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 275 (estimated)
- First submitted
- 3 Aug 2025
- Start date
- 18 Aug 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- The University of Queensland
- Diseases
- Parkinson disease
- NCT number
- NCT07114354
What you commit to
- Study type: Interventional
- Planned participants: 275
- From 18 Aug 2025 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with severe Parkinson's disease who aren't able to communicate
- People with comorbid neurological conditions (e.g. Stroke)
Who the study is looking for
- People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.